IFIH1 and dermatomyositis: Here we reported a case of anti‐MDA5 antibody‐positive DM‐ILD patients who were treated with hormones and immunosuppressive agents in combination with tofacitinib and had negative anti‐MDA5 antibodies, which is summarized below for clinical reference.